Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Pharmaceutical and Device
PhRMA DTC Guidelines: Welcome Revisions
In an effort to be more physician and patient friendly PhRMA today released a set of Guiding Principles for direct to consumer…
Pfizer Bextra: Settling Big
Last week Pfizer announced a huge $894 million dollar settlement with patients, the Federal Government and States Attorney…
Eli Lilly: Settles Down with State AG’s
Yesterday Eli Lilly settled a consumer protection lawsuit on Zyprexa, one of their psychiatric drugs, for $62 million with 32…
Physician Payment Sunshine: Cephalon Agreement to Act
Every industry has its bad actors. In the case of pharmaceutical companies the bad actors fall into two categories; those…
Pfizer Cardiovascular: The End of an Era
Pfizer announced WSJ: Pfizer Plans to Abandon Heart-Drug Development that they are giving up on the Cardiovascular business…
Physician Payment Sunshine: Merck Joins the Act
In a move to give the public more transparency around physician payments and grants Merck announced that starting in October,…
Physician Payment Sunshine: Eli Lilly Acts
In a move to provide greater transparency of payments for consulting and speaking to physicians, Eli Lilly Announced today that…
Top Researchers Encourage Collaboration
Marc Feldmann and Ravinder Maini, scientists from the Kennedy Institute of Rheumatology at Imperial College London. …
The Return of the Sopranos?
What did the photographer have in mind.... What were they thinking... Is this the image senior management is trying to…
Drug Development – The need for a little serendipity
Why does drug development require so much serendipity? Why do drugs take so long to develop? Why is there are there…